Skip to content
Medical Health Aged Care

Estia Health completes acquisition of Robina Rise, Noosa, and Gympie Views residential aged care homes from Calvary Health Care

Estia Health < 1 mins read

MEDIA RELEASE

  • Estia Health strengthens Queensland presence with acquisition
  • No change for residents in the homes
  • Continuity of employment with Estia Health for current employees

 

Estia Health has completed the acquisition of three residential aged care homes previously operated by Calvary Health Care in Robina, Noosa, and Gympie. The homes are now officially owned and operated by Estia Health, expanding the company’s footprint in key Queensland regions.

Sean Bilton, CEO Estia Health said: “We are delighted to be able to increase our commitment to the Sunshine Coast and Gold Coast through the management of an additional 406 residential aged care places, for older Queenslanders.”

“We want to assure all residents and their families that they will continue to receive the same dedicated care and services from the same people that they always have,” Bilton said. “As a provider of residential aged care homes across Australia, we are proud to offer individualised care and support to our residents and their families at an incredibly important time in their lives.”

The acquisition of these three aged care homes reinforces Estia Health’s position as one of Australia’s leading aged care providers, now operating 78 homes nationwide. This expansion demonstrates the company’s ongoing commitment to providing high-quality, person-centred care to older Australians.

Ends

For media enquiries:
Julie Connolly
John Connolly & Partners
[email protected]

 

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.